Global Market Study on Microfluidic Devices: Asia to Witness Highest Growth by 2019

107
Published Date: 2014-08-26

Microfluidics is an evolving scientific field with numerous analytical applications and commercial potential. Microfluidics is an enabling technology for integration, industrialization, miniaturization and parallelization of tests in diagnostics, drug development and biological research. Microfluidic devices have several applications in the field of medicine, cell biology research and protein crystallization. It also has many applications in other areas such as drug screening, sugar testers, chemical micro reactor, microprocessor cooling and micro fuel cells.


North America dominates the global microfluidic devices market. Rising aging population, increasing health awareness, rising chronic and lifestyle diseases, technological developments for various home use applications, and proper insurance coverage are driving the use of microfluidic devices in the market. Similarly, in Europe, the microfluidic device market is driven by rising diagnostic requirements due to increasing lifestyle associated diseases, aging population and improving healthcare infrastructure. Asia is becoming one of the most attractive markets for medical device companies. The growth for microfluidic devices is much faster than developed countries due to widening health insurance penetration and up-gradation of health care systems.


Rising demand for point of care testing, miniaturization of chip, and increasing demand for microfluidic devices in genomics and proteomics are the key growth drivers for the microfluidic device market. New trends in healthcare, such as healthcare at home supports point of care testing (POCT) as the most efficient and effective delivery of healthcare. Miniaturization reduces the cost for screening compounds in pharmaceutical companies for cell biology problems. On the other hand, strict regulatory requirements are a major concern for the industry. Safety, performance and consistent quality of medical devices are a necessity for public health. Thus, it leads to strict and complex regulations and standards for global affiliation of medical devices.


Different materials such as glass, silicon, polymer metal and ceramics, are used to manufacture microfluidic devices. Change in material mix would provide opportunity for new market entrants, which would further drive the growth of the microfluidic device market. Research and commercialization emphasis has shifted to micro devices made entirely from polymeric material. However, major challenges faced by the microfluidic devices industry are the geometrical and surface chemistry issues during manufacturing of a device. In complex microfluidic devices, geometrical and surface chemistry issues combine and lead to design and manufacturing difficulties


This report provides an in-depth analysis of estimation of the microfluidic device market for the period 2013-2019, considering 2013 as the base year for calculation. In addition, data pertaining to current market dynamics including market drivers, restraints, trends and strategic developments has been provided in the report. The microfluidic device market is categorized on the basis of material used for manufacturing microfluidic devices, industry, application and geography. Based on industry, the microfluidic device market comprises in-vitro diagnostics, pharmaceuticals and medical devices. The application market comprises point of care testing, analytical devices, pharmaceutical and life science research, clinical and veterinary diagnostics, drug delivery and environment and industry.


In the geographical analysis, the report identifies and analyses market size and forecast of North America, Europe, Asia and Rest of the World (Row). Some of the major players in the microfluidic device market are Roche Diagnostics, Abbott Laboratories, Siemens Healthcare, Agilent Technologies, Bio-Rad Laboratories, Inc, Fluidigm Corporation and Johnson & Johnson. These key market players have been profiled on the basis of attributes such as company overview, recent developments, growth strategies, sustainability, and financial overview.

Table of Content


Chapter 1 Preface 11

1.1 Report Description 11

1.2 Research Methodology 12

1.3 Assumptions 12


Chapter 2 Market Synopsis 13


Chapter 3 Porter Five Forces Analysis 15

3.1 Bargaining power of suppliers 15

3.2 Bargaining power of buyers 16

3.3 Threat of new entrants 16

3.4 Threat of substitutes 16

3.5 Intensity of rivalry 16


Chapter 4 Industry Overview 17

4.1 Market Definition 17

4.2 Market Drivers 19

      4.2.1 Rising demand for point of care testing 19

      4.2.2 Miniaturization of chip, reduces the cost of testing 20

      4.2.3 Increasing demand of microfluidic devices in genomics and proteomics 21

      4.2.4 Change in material mix provides new opportunities for new players in the market 21

4.3 Impact Analysis of Market Drivers 22

4.4 Market Restraints 22

      4.4.1 Strict regulatory requirements 23

      4.4.2 Geometrical and surface chemistry issues are a challenge for microfluidics 24

4.5 Impact Analysis of Market Restraints 24

4.6 Market Trends 25

      4.6.1 Rising number of collaborations and partnerships 25

      4.6.2 Rising number of product innovations 25


Chapter 5 Global Market Size and Forecast 27


Chapter 6 Market Size and Forecast by Material 34

6.1 Glass 34

6.2 Polymer 36

6.3 Silicon 38


Chapter 7 Market Size and Forecast by Industry 41

7.1 In-vitro diagnostics 41

7.2 Pharmaceutical 43

7.3 Medical Devices 49


Chapter 8 Market Size and Forecast by Industry 53

8.1 Point of care testing 53

8.2 Pharmaceutical and life science research 55

8.3 Drug Delivery 58

8.4 Analytical devices 60

8.5 Clinical and veterinary diagnostics 63

8.6 Environment and Industrial 65


Chapter 9 Market Size and Forecast by Geography 69

9.1 North America 69

9.2 Europe 71

9.3 Asia 74

9.4 Rest of the World 76


Chapter 10 Competitive Scenario 78

10.1 Competitive Benchmarking 78


Chapter 11 Company Profiles 80

11.1 Roche Diagnostics 80

      11.1.1 Company Overview 80

      11.1.2 Products and Services 80

      11.1.3 Financial Performance 81

      11.1.4 Recent Developments 81

11.2 Abbott Laboratories 83

      11.2.1 Company Overview 83

      11.2.2 Products and Services 83

      11.2.3 Financial Performance 84

      11.2.4 Recent Developments 85

11.3 Siemens Healthcare 86

      11.3.1 Company Overview 86

      11.3.2 Products and Services 86

      11.3.3 Financial Performance 87

      11.3.4 Recent Developments 87

11.4 Agilent Technologies, Inc 88

      11.4.1 Company Overview 88

      11.4.2 Products and Services 88

      11.4.3 Financial Performance 89

      11.4.4 Recent Developments 89

11.5 Fluidigm Corporation 90

      11.5.1 Company Overview 90

      11.5.2 Products and Services 90

      11.5.3 Financial Performance 90

      11.5.4 Recent Developments 91

11.6 Bio-Rad Laboratories, Inc. 93

      11.6.1 Company Overview 93

      11.6.2 Products and Services 93

      11.6.3 Financial Performance 94

      11.6.4 Recent Developments 94

11.7 Cepheid 95

      11.7.1 Company Overview 95

      11.7.2 Products and Services 95

      11.7.3 Financial Performance 95

      11.7.4 Recent Developments 96

11.8 RainDance Technologies, Inc. 98

      11.8.1 Company Overview 98

      11.8.2 Products and Services 98

      11.8.3 Financial Performance 98

      11.8.4 Recent Developments 99

11.9 Dolomite Centre 100

      11.9.1 Company Overview 100

      11.9.2 Products and Services 100

      11.9.3 Financial Performance 100

      11.9.4 Recent Developments 100

11.10 Micronit Microfluidics 102

      11.10.1 Company Overview 102

      11.10.2 Products and Services 102

      11.10.3 Financial Performance 102

      11.10.4 Recent Developments 102

11.11 Johnson & Johnson 103

      11.11.1 Company Overview 103

      11.11.2 Products and Services 103

      11.11.3 Financial Performance 103

      11.11.4 Recent Developments 104

11.12 Becton, Dickinson and Company 105

      11.12.1 Company Overview 105

      11.12.2 Products and Services 105

      11.12.3 Financial Performance 106

      11.12.4 Recent Developments 106

Microfluidics is an evolving scientific field with numerous analytical applications and commercial potential. It has several applications in the field of medicine, cell biology research and protein crystallization. Thus, microfluidic technology is an important tool to reduce side effects and improve the efficacy of treatments. Globally, the microfluidic device market is witnessing significant growth due to increasing R&D investment in pharmaceuticals, life science and rising point of care testing demand. New trends in healthcare, such as healthcare at home, supports point of care testing (POCT) as the most efficient and effective delivery of healthcare. Additionally, the microfluidic technique has evolved into a new classification of research areas, targeting integration of laboratory protocols into miniaturized devices called lab on chip. Miniaturization reduces the cost for screening compounds in pharmaceutical companies for cell biology problems. Microfluidic devices offer various advantages for genomics including improved test speed, reduced reagent consumption and efficacy. The global microfluidic device market was valued at USD 1,531.2 million in 2013. It is likely to grow at a CAGR of 22.8% during 2013 to 2019 to reach USD 5,246.4 million in 2019.


North America has the largest share in the global microfluidic device market. In-vitro diagnostics is the largest industry, and clinical and veterinary diagnostics is the largest application of microfluidic device market. In terms of growth, Asia is the fastest growing region, medical devices are the fastest growing industry and point of care testing is the fastest growing application of microfluidic devices.


North America was valued at USD 644.5 million in 2013 and is expected to reach USD 2,095.5 million in 2019, growing at a CAGR of 21.7% from 2013 to 2019.


Point of care testing in the global microfluidic device market was valued at USD 316.7 million in 2013 and is expected to reach USD 1,412.1 million in 2019, growing at a CAGR of 28.3% from 2013 to 2019.